Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Patent (7)
- Research (5)
- Technology transfer (5)
- R & D (4)
- Biotech (3)
-
- Federal funding (3)
- DNA (2)
- NIH (2)
- Patents (2)
- Protection (2)
- Public (2)
- Access (1)
- Algorithms (1)
- Beta-carotene (1)
- CDNA (1)
- Confidentiality (1)
- Control (1)
- Copyright (1)
- Developing world (1)
- Development (1)
- Discovery (1)
- Disease (1)
- Drug (1)
- Employers (1)
- Employment (1)
- FTTA (1)
- Fact (1)
- GMOs (1)
- Gene sequencing (1)
- Genetic (1)
Articles 1 - 12 of 12
Full-Text Articles in Life Sciences
Golden Rice: A Case Study In Intellectual Property Management And International Capacity Building, Stanley P. Kowalski, R. David Kryder
Golden Rice: A Case Study In Intellectual Property Management And International Capacity Building, Stanley P. Kowalski, R. David Kryder
RISK: Health, Safety & Environment (1990-2002)
The authors examine the management of risks associated with intellectual property linked to agri-biotech products, with emphasis on the international movement of agri-biotech intellectual property from industrialized to developing nations.
Genome Research And Traditional Intellectual Property Protection -- A Bad Fit?, Kate H. Murashige
Genome Research And Traditional Intellectual Property Protection -- A Bad Fit?, Kate H. Murashige
RISK: Health, Safety & Environment (1990-2002)
Dr. Murashige addresses the need for a patent system more closely tailored to the needs of biotechnology. For example, the obviousness requirement may interfere with using patents to recoup high costs of work when it could arguably be done by researchers of ordinary skill.
Impact Of The Human Genome Project At The Interface Between Patent And Fda Laws, Brian C. Cunningham
Impact Of The Human Genome Project At The Interface Between Patent And Fda Laws, Brian C. Cunningham
RISK: Health, Safety & Environment (1990-2002)
Mr. Cunningham stresses the broad scope of biotechnological innovations. Besides endorsing the need for a new oversight commission to deal with potential social issues, he suggests, for example, that some products should be treated like biologics rather than new drugs.
Social Issues Of Genome Innovation And Intellectual Property, Elaine Alma Draper
Social Issues Of Genome Innovation And Intellectual Property, Elaine Alma Draper
RISK: Health, Safety & Environment (1990-2002)
Dr. Draper's focus is the use of personal information derived from genome research. She identifies several potential problems, including access to and control of genetic information, employment discrimination and social stratification. She also recommends possible solutions.
Development Of Vaccines To Meet Public Health Needs: Incentives And Obstacles, Phillip K. Russell
Development Of Vaccines To Meet Public Health Needs: Incentives And Obstacles, Phillip K. Russell
RISK: Health, Safety & Environment (1990-2002)
Dr. Russell explains how such matters as high 'costs of regulation, lack of an effective plan for delivery (particularly abroad) and politics can interfere with providing globally needed vaccines.
Overview Of Federal Technology Transfer, Lawrence Rudolph
Overview Of Federal Technology Transfer, Lawrence Rudolph
RISK: Health, Safety & Environment (1990-2002)
Mr. Rudolph reviews approximately thirteen years of legal and political developments that have contributed to laws governing the extent to which private firms may secure rights in technology at least partly developed with federal funds.
The Human Genome Project And The Downside Of Federal Technology Transfer, Christopher J. Harnett
The Human Genome Project And The Downside Of Federal Technology Transfer, Christopher J. Harnett
RISK: Health, Safety & Environment (1990-2002)
Mr. Harnett argues that emphasizing technology transfer at institutions such as the National Institutes of Health will interfere with what should be regarded as their primary mission, basic research.
Technology Transfer: A View From The Trenches, Harvey Drucker
Technology Transfer: A View From The Trenches, Harvey Drucker
RISK: Health, Safety & Environment (1990-2002)
Dr. Drucker, who has lab-wide responsibility for technology transfer at Argonne National Laboratory, argues that transferring rights in discoveries made through tax supported research to private entities can contribute to public welfare in many ways.
Biotechnology Process Patents: Is Special Legislation Needed?, Timothy P. Linkkila, Timothy E. Tracy
Biotechnology Process Patents: Is Special Legislation Needed?, Timothy P. Linkkila, Timothy E. Tracy
RISK: Health, Safety & Environment (1990-2002)
The authors review administrative and court decisions prompting proposed changes to the patent law. After reviewing pros and cons, they argue that, on balance, pending bills can easily cause more problems than they solve.
Overview Of Potential Intellectual Property Protection For Biotechnology, Kate H. Murashige
Overview Of Potential Intellectual Property Protection For Biotechnology, Kate H. Murashige
RISK: Health, Safety & Environment (1990-2002)
Dr. Murashige compares the function and value of copyright, patent and trade secret laws in recovering investments in developing genome-related biotechnology.
Technology Transfer And The Genome Project: Problems With Patenting Research Tools, Rebecca S. Eisenberg
Technology Transfer And The Genome Project: Problems With Patenting Research Tools, Rebecca S. Eisenberg
RISK: Health, Safety & Environment (1990-2002)
Professor Eisenberg argues against a system providing for federally-sponsored inventions to be patented if any associated person so desires. She believes that the system does not adequately weigh the possibility that the greatest social return from genome research will require some discoveries to be in the public domain.
[Introduction] The Science Court Is Dead - Long Live The Science Court, Thomas G. Field
[Introduction] The Science Court Is Dead - Long Live The Science Court, Thomas G. Field
RISK: Health, Safety & Environment (1990-2002)
[Excerpt] "It is a pleasure to introduce this symposium issue with its range of current thoughts about what Arthur Kantrowitz invented a little over twenty-five years ago and has since come to be known as the "Science Court." The pleasure is enhanced by being able to include papers by Dr. Kantrowitz, Allan Mazur (who worked closely with him), Carl Cranor, Itzhak Jacoby and Sheila Jasanoff - as well as an extensive list of citations to other discussions. In approaching these papers, readers may find it helpful to consider what Kantrowitz invented, he and others have attempted to improve, and the …